IP Library Granted Patent US 8,802,392
Granted Patent B2
US 8,802,392 · App. 13/825,881 · Granted Aug 12, 2014

Method of determining efficacy of a sterilization process

Inventors: Sailaja Chandrapati (Woodbury, MN); Heather M. Webb (Woodbury, MN); Jeffrey C. Pederson (Minneapolis, MN); Kurt J. Halverson (Lake Elmo, MN); Brian R. Engel (Houston, TX)
Assignee: 3M Innovative Properties Company
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,802,392
App. No.
13/825,881
Granted
Aug 12, 2014
Kind
B2
Abstract

The present invention provides method of detecting a predetermined biological activity. The method includes using an aqueous mixture comprising a first indicator reagent with a first absorption spectrum and a second indicator reagent. The second indicator reagent is converted by the predetermined biological activity to a second biological derivative with a second emission spectrum. The first absorbance spectrum includes detectable absorbance in at least a portion of wavelengths present in the second emission spectrum. The first indicator reagent is received and concentrated from an aqueous liquid by a substrate, facilitating the detection of the second biological derivative.

Claims (17)

1. A method of determining the efficacy of a sterilization process, comprising:

providing a biological sterilization indicator comprising;

a housing;

a container containing an aqueous liquid;

a source of predetermined enzyme activity that is inactivated by a sterilant;

a first indicator reagent with a first absorbance spectrum;

a second indicator reagent that is converted by the source of predetermined enzyme activity to a biological derivative with a second fluorescence emission spectrum;

wherein the first absorbance spectrum includes detectable absorbance in at least a portion of wavelengths of the second fluorescence emission spectrum;

a substrate that receives and concentrates the first indicator reagent from the aqueous liquid;

providing an instrument that detects the biological derivative, wherein the instrument comprises an optical path;

exposing the predetermined enzyme activity to the sterilant;

bringing the predetermined enzyme activity, the first indicator reagent, the second indicator reagent, and the substrate into fluid communication with the aqueous liquid; and

detecting a quantity of fluorescene from the biological derivative in the aqueous liquid;

wherein detecting the quantity of fluorescence from the biological derivative comprises using the instrument;

wherein detecting the quantity of fluorescence comprises positioning the housing in the optical path passes through the aqueous liquid but does not intersect the substrate;

wherein the quantity of fluorescence is an indication of the efficacy of the sterilization process.

2. The method of claim 1 , further comprising detecting a color associated with the substrate, wherein the color is associated with a biological derivative of the first indicator reagent, wherein the color is an indication of the efficacy of the sterilization process.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066435/0347 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2013
From: CHANDRAPATI, SAILAJA; WEBB, HEATHER M.; PEDERSON, JEFFREY C.; HALVERSON, KURT J.; ENGEL, BRIAN J.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 030077/0335 →
Continuity (3)
Provisional Application 61408966 · Nov 1, 2010
Provisional Application 61408977 · Nov 1, 2010
Related Publication 20130210067A1 · Aug 15, 2013